<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

    <MetaVariables>
        <Submitter/>
        <Method/>
    </MetaVariables>
    <MetaLinks/>

    <Projects>
        <Project/>
    </Projects>

    <Studies>

        <Study source="dbGaP" accession="phs001894.v1.p1" parentStudy="phs001894.v1.p1" createDate="2019-09-04"
               modDate="2020-04-07">

            <Configuration>
                <Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Tom Maniatis, PhD</td><td>New York Genome Center, New York, NY, USA</td></tr>
		<tr><td>Principal Investigator</td><td>Michael Zody, PhD</td><td>New York Genome Center, New York, NY, USA</td></tr>
		<tr><td>Principal Investigator</td><td>Michael Wigler, PhD</td><td>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA</td></tr>
		<tr><td>Funding Source</td><td>UM1HG008901</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
                <StudyNameEntrez>CCDG-Neuropsychiatric: Autism- Genetics of Human Developmental Brain Disorders
                </StudyNameEntrez>
                <StudyNameReportPage>Center for Common Disease Genomics (CCDG) Neuropsychiatric: Homozygosity Mapping
                    Consortium for Autism (HMCA)
                </StudyNameReportPage>
                <StudyTypes>
                    <StudyType>Family</StudyType>
                    <StudyType>Cohort</StudyType>
                </StudyTypes>
                <Description><![CDATA[
<p>In this study, we address the enormous challenges common complex diseases pose for genomic analysis and the enormous opportunities surmounting them offers for advancing healthcare. The common genetic disorders proposed for study are believed to have extreme locus heterogeneity, requiring the analysis of large numbers of samples to comprehensively identify the genomic variants underlying them. We propose that a combination of deep population studies and joint analysis of SNPs, indels, and structural variants, both in coding and noncoding regions, will provide the next level of understanding of common genetic disorders. Whole genome sequencing (WGS) will be critical to this next-generation approach to the genomics of complex disease. WGS will need to be accompanied by the technical ability to generate and handle very large data sets, a particular focus and strength of NYGC. WGS will also need to be accompanied by new statistical tools and algorithms, which will be developed by the strong core group committed to this proposal. An overarching goal of this proposal, one that capitalizes on the power of WGS, is to identify disease-associated variants at the individual nucleotide level. In many cases, pathogenic mutations fall in noncoding regions of the genome, which can only be fruitfully explored with WGS. A major effort was put into building new computational strategies to functionally annotate noncoding transcribed sequences, and to build new datasets to enable such strategies, opening new frontiers of understanding of disease-related regulatory variants.</p>]]>
                </Description>
                <StudyProjects>
                    <Project/>
                </StudyProjects>
                <Publications>
                    <Publication>
                        <Pubmed pmid="28630308"/>
                    </Publication>
                    <Publication>
                        <Pubmed pmid="28436466"/>
                    </Publication>
                    <Publication>
                        <Pubmed pmid="28910620"/>
                    </Publication>
                    <Publication>
                        <Pubmed pmid="28797091"/>
                    </Publication>
                    <Publication>
                        <Pubmed pmid="29161423"/>
                    </Publication>
                    <Publication>
                        <Pubmed pmid="29434036"/>
                    </Publication>
                    <Publication>
                        <Pubmed pmid="29578408"/>
                    </Publication>
                    <Publication>
                        <Pubmed pmid="29021289"/>
                    </Publication>
                    <Publication>
                        <Pubmed pmid="28759029"/>
                    </Publication>
                    <Publication>
                        <Pubmed pmid="28814792"/>
                    </Publication>
                    <Publication>
                        <Pubmed pmid="27863238"/>
                    </Publication>
                </Publications>
                <Diseases>
                    <Disease vocab_source="MESH" vocab_term="Autism Spectrum Disorder"/>
                </Diseases>
                <Attributions>
                    <Header title="Principal Investigator">
                        <AttName>Tom Maniatis, PhD</AttName>
                        <Institution>New York Genome Center, New York, NY, USA</Institution>
                    </Header>
                    <Header title="Principal Investigator">
                        <AttName>Michael Zody, PhD</AttName>
                        <Institution>New York Genome Center, New York, NY, USA</Institution>
                    </Header>
                    <Header title="Principal Investigator">
                        <AttName>Michael Wigler, PhD</AttName>
                        <Institution>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA</Institution>
                    </Header>
                    <Header title="Funding Source">
                        <AttName>UM1HG008901</AttName>
                        <Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
                    </Header>
                </Attributions>
                <DisplayPublicSummary>yes</DisplayPublicSummary>
                <ConsentGroups>
                    <ConsentGroup groupNum="2" shortName="DS-EAC-PUB-GSO"
                                  longName="Disease-Specific (Epilepsy and Cognition, PUB, GSO)"/>
                </ConsentGroups>
            </Configuration>

            <AuthorizedAccess>
                <DacInfo ssDacId="0">
                    <DacName>NHGRI</DacName>
                    <DacFullName>National Human Genome Research Institute</DacFullName>
                    <DacEmail>0</DacEmail>
                    <DacPhone/>
                    <DacUrl/>
                </DacInfo>
                <Policy Policy_ID="phs001894.v1.p1_policy" ref_ssDacId="0">
                    <DisplayResearchStatement>yes</DisplayResearchStatement>
                    <DisplayPublicSummary>yes</DisplayPublicSummary>
                    <EmbargoLength>0</EmbargoLength>
                    <YearsUntilRenewal>1</YearsUntilRenewal>
                    <WeeksCancelRequest>8</WeeksCancelRequest>
                    <PdfSupplementReqired>no</PdfSupplementReqired>
                    <AcknowledgementText>
                        <para>
                            http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs001894.v1.p1
                        </para>
                    </AcknowledgementText>
                    <DocumentSet>
                        <DataUseCertificate Label="Data Use Certificate"
                                            FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs001894.v1.p1"
                                            FileName=""/>
                    </DocumentSet>
                </Policy>
                <ConsentGroups>
                    <ParticipantSet groupNum-REF="2">
                        <ConsentName>Disease-Specific (Epilepsy and Cognition, PUB, GSO)</ConsentName>
                        <ConsentAbbrev>DS-EAC-PUB-GSO</ConsentAbbrev>
                        <UseLimitation>Use of the data must be related to Epilepsy and Cognition.
                            Requestor agrees to make results of studies using the data available to the larger
                            scientific community.
                            Use of the data is limited to genetic studies only.
                            Limited to study of genetic causes of human neurological disorders of epilepsy and
                            cognition. This includes disorders of brain formation such as microcephaly (small brain),
                            lissencephaly (smooth brain), and polymicrogyria (too many small folds in the brain
                            surface), disorders of brain function such as intellectual disability and autism, and other
                            related conditions.
                        </UseLimitation>
                        <IrbRequired>No</IrbRequired>
                    </ParticipantSet>
                </ConsentGroups>
            </AuthorizedAccess>


        </Study>

    </Studies>

</GaPExchange>
